Novel splice-site and recurrent p.Arg729* CNKSR2 variants in ESES/CSWS: insights into sex-dependent expression.

SeizureJul 19, 2026 (epub)

Adnan Deniz, Eyyüp Üçtepe, Fatma Müjgan Sönmez

✦ AI-curated · Sources linked

Case in brief

This report describes two patients with de novo CNKSR2 variants. A 17-year-old female presented with a novel splice-site variant and a relatively mild phenotype, while an 8-year-old male exhibited a recurrent nonsense variant leading to drug-resistant ESES, autism, and severe language impairment. These cases highlight the variability in clinical presentation associated with CNKSR2 mutations.

What made this case unusual

The female patient exhibited a mild phenotype despite carrying a pathogenic variant, contrasting with the typically severe manifestations seen in hemizygous males.

Diagnostic / clinical pearl

Clinicians should consider CNKSR2 mutations in patients with ESES/CSWS, regardless of sex, due to the potential for variable phenotypic expression.

Why it matters

Understanding the sex-dependent variability in CNKSR2-related disorders can aid in better diagnosis and management of affected individuals, particularly females who may present with milder symptoms.

Source

Published in Seizure. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Medical Genetics

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.